Australia's most trusted
source of pharma news
Thursday, 05 December 2024
Posted 1 August 2022 PM
PBS listings keep rolling in to mark the first day of the month today (Monday), with expansions making a big showing.
Janssen's schizophrenia drug Invega Hafyera won a PBS berth while at least five drugs already reimbursed have been expanded.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.